Top Suppliers:I want be here
Related CAS#:
1540676-03-6 1426408-95-8
114589-00-3 1426409-11-1
476661-10-6 1550823-31-8
255871-18-2 1545012-58-5
1429214-44-7 1429199-83-6

35700-23-3

35700-23-3 structure
35700-23-3 structure
  • Name: Carboprost
  • Chemical Name: carboprost
  • CAS Number: 35700-23-3
  • Molecular Formula: C21H36O5
  • Molecular Weight: 368.508
  • Catalog: API Hormone and endocrine-regulating drugs Prostaglandins
  • Create Date: 2018-05-26 08:00:00
  • Modify Date: 2026-06-30 17:03:05
  • Carboprost (15(S)-15-Methyl Prostaglandin F2α) is a metabolically stable synthetic analog of prostaglandin F2α. Carboprost stimulates uterine contractions and induces abortion. Carboprost is used for postpartum hemorrhage due to uterine atony and for the termination of pregnancy in the second trimester[1][2].
Name carboprost
Synonyms 15(s)-15-methylpgf2-alpha
15-Methylprostaglandin F2a
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-Methyl-, (5Z,9α,11α,13E,15S)
Methyl-pgf2a
cbopros
trimester,uterine,Inhibitor,postptum,abortion,atony,F2α,prostaglandin,hemorrhage,second,pregnancy,inhibit,contractions,Cboprost,termination
(5Z,13E,15S)-9α,11α,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid
(15S)-15-Methyl-PGF2α
prosta-5,13-dien-1-oicacid,9,11,15-trihydroxy-15-methyl-,(5z,9-alpha,11-alph
(15S)-15-Methylprostaglandin F2α
15-Methyl-PGF2a
(5z,9-alpha,11-alpha,13e,15s)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1
Cboprost, 10 mM in DMSO
15-methylpgf2-alpha
Cboprost Trometamol Impurity B (Cboprost)
methyldinoprost
15(s)-methylprostaglandinf2-alpha
(15S)-15-Methyl-PGF2a
15-me-pgf2-alpha
(15S)-15-Methyl PGF2a
15-methyl-pgf2alpha
15(S)-15-methylProstaglandinF2a
15(S)-15-METHYL PROSTAGLANDIN F2ALPHA
prostin15m
15-methyl prostaglandin f2alpha
U-32921
9ALPHA,11ALPHA,15S-TRIHYDROXY-15-METHYL-PROSTA-5Z,13E-DIEN-1-OIC ACID
methyl-pgf2-alpha
oicacid
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-3-methyl-1-octenyl))cyclopentyl)-5-heptenoic acid
15s)-13e
Cboprost Trometamol Impurity B
(z)-7-[(3r,5s)-3,5-dihydroxy-2-[(e,3s)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]ht-5-enoic acid
15-ME-PGF2a
(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic Acid
(15S)-15-Methylprostaglandin F2a
15-methyl-15S-PGF2α
15-methyl-prostaglandin F2
(5Z,9α,11α,13E,15S)-9,11,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid
C06872
15-Methyl-PGF2α
CBOPROST
MFCD00135249
Cboprost //BP
U-32921E
Description Carboprost (15(S)-15-Methyl Prostaglandin F2α) is a metabolically stable synthetic analog of prostaglandin F2α. Carboprost stimulates uterine contractions and induces abortion. Carboprost is used for postpartum hemorrhage due to uterine atony and for the termination of pregnancy in the second trimester[1][2].
Related Catalog
In Vivo The methyl ester of Carboprost (15(S)-15-Methyl Prostaglandin F2α; 15M-PGF2 alpha, 12.5 mg/monkey) loweres serum progesterone to 12% of pretreatment values within 24 hours, however progesterone returnes to normal limits within 48 hours[1].
References

[1]. S J Carlan, et al. Effect of Intramuscular 15-methyl Prostaglandin F2 Alpha After Second-Trimester Delivery. Obstet Gynecol. 1997 Jan;89(1):5-9.

[2]. J W Wilks, et al. Inhibition of the Monkey Corpus Luteum With 15-methyl Prostaglandins. Prostaglandins. 1980 Nov;20(5):793-805.
Density 1.1±0.1 g/cm3
Boiling Point 536.6±50.0 °C at 760 mmHg
Melting Point 79-82ºC
Molecular Formula C21H36O5
Molecular Weight 368.508
Flash Point 292.4±26.6 °C
Exact Mass 368.256287
PSA 97.99000
LogP 2.49
Vapour Pressure 0.0±3.2 mmHg at 25°C
Index of Refraction 1.565
Storage condition -20°C Freezer, Under Inert Atmosphere

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UK8021000
CHEMICAL NAME :
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9-alpha,11-alpha,13E,15S)-
CAS REGISTRY NUMBER :
35700-23-3
LAST UPDATED :
199612
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C21-H36-O5
MOLECULAR WEIGHT :
368.57

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
5 ug/kg
SEX/DURATION :
female 14 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
JOGBAS Journal of Obstetrics and Gynaecology of the British Commonwealth. (London, UK) V.68-81, 1961-74. For publisher information, see BJOGAS. Volume(issue)/page/year: 79,737,1972
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
12 ug/kg
SEX/DURATION :
female 30 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
PRGLBA Prostaglandins. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1972- Volume(issue)/page/year: 14,785,1977
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraplacental
DOSE :
10 ug/kg
SEX/DURATION :
female 13 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
JOGBAS Journal of Obstetrics and Gynaecology of the British Commonwealth. (London, UK) V.68-81, 1961-74. For publisher information, see BJOGAS. Volume(issue)/page/year: 79,737,1972
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
60 ug/kg
SEX/DURATION :
female 42 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
CCPTAY Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970- Volume(issue)/page/year: 21,273,1980
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
10 ug/kg
SEX/DURATION :
female 15 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
JOGBAS Journal of Obstetrics and Gynaecology of the British Commonwealth. (London, UK) V.68-81, 1961-74. For publisher information, see BJOGAS. Volume(issue)/page/year: 79,737,1972
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
100 ug/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
REFERENCE :
CYLPDN Zhongguo Yaoli Xuebao. Acta Pharmacologica Sinica. Chinese Journal of Pharmacology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1980- Volume(issue)/page/year: 8,540,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
500 ug/kg
SEX/DURATION :
female 1 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - other measures of fertility
REFERENCE :
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 151,575,1976 *** REVIEWS *** TOXICOLOGY REVIEW AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 113,130,1972
Hazard Codes Xi
Risk Phrases R36:Irritating to the eyes.
Safety Phrases S26-S37/39
WGK Germany 2
RTECS TU0175000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:35700-23-3 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 35700-23-3 | Chemsrc address: https://m.chemsrc.com/en/baike/335787.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2026 ChemSrc All Rights Reserved